Human Metabolome Technologies, Inc. (TYO:6090)
600.00
-23.00 (-3.69%)
Jun 4, 2026, 3:30 PM JST
TYO:6090 Revenue
Human Metabolome Technologies had revenue of 448.00M JPY in the quarter ending March 31, 2026, a decrease of -23.02%. This brings the company's revenue in the last twelve months to 1.30B, down -13.37% year-over-year. In the fiscal year ending June 30, 2025, Human Metabolome Technologies had annual revenue of 1.46B with 8.18% growth.
Revenue (ttm)
1.30B
Revenue Growth
-13.37%
P/S Ratio
2.61
Revenue / Employee
20.90M
Employees
62
Market Cap
3.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.46B | 110.00M | 8.18% |
| Jun 30, 2024 | 1.35B | 46.00M | 3.54% |
| Jun 30, 2023 | 1.30B | 76.00M | 6.21% |
| Jun 30, 2022 | 1.22B | 99.00M | 8.81% |
| Jun 30, 2021 | 1.12B | 6.00M | 0.54% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.51T |
| Otsuka Holdings | 2.52T |
| Chugai Pharmaceutical | 1.29T |
| HOYA Corporation | 947.75B |
| Miahelsa Holdings | 24.85B |
| Transgenic Group | 13.17B |
| Platz | 8.38B |
| MRT Inc. | 4.10B |